Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

NDRG2: a novel Alzheimer's disease associated protein.

Mitchelmore C, Büchmann-Møller S, Rask L, West MJ, Troncoso JC, Jensen NA.

Neurobiol Dis. 2004 Jun;16(1):48-58.

PMID:
15207261
2.

The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease.

von Rotz RC, Kins S, Hipfel R, von der Kammer H, Nitsch RM.

Eur J Neurosci. 2005 Mar;21(5):1289-98.

PMID:
15813938
3.

Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain.

Abad MA, Enguita M, DeGregorio-Rocasolano N, Ferrer I, Trullas R.

J Neurosci. 2006 Dec 6;26(49):12735-47.

4.

Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease.

Chin J, Massaro CM, Palop JJ, Thwin MT, Yu GQ, Bien-Ly N, Bender A, Mucke L.

J Neurosci. 2007 Mar 14;27(11):2727-33.

5.

mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.

Lafay-Chebassier C, Paccalin M, Page G, Barc-Pain S, Perault-Pochat MC, Gil R, Pradier L, Hugon J.

J Neurochem. 2005 Jul;94(1):215-25.

6.

Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.

Mohri I, Kadoyama K, Kanekiyo T, Sato Y, Kagitani-Shimono K, Saito Y, Suzuki K, Kudo T, Takeda M, Urade Y, Murayama S, Taniike M.

J Neuropathol Exp Neurol. 2007 Jun;66(6):469-80.

PMID:
17549007
7.

Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 mice.

Biscaro B, Lindvall O, Hock C, Ekdahl CT, Nitsch RM.

J Neurosci. 2009 Nov 11;29(45):14108-19. doi: 10.1523/JNEUROSCI.2055-09.2009.

8.

Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease.

Page G, Rioux Bilan A, Ingrand S, Lafay-Chebassier C, Pain S, Perault Pochat MC, Bouras C, Bayer T, Hugon J.

Neuroscience. 2006;139(4):1343-54. Epub 2006 Apr 3.

PMID:
16581193
9.

Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.

Jack CR Jr, Marjanska M, Wengenack TM, Reyes DA, Curran GL, Lin J, Preboske GM, Poduslo JF, Garwood M.

Neuroscientist. 2007 Feb;13(1):38-48. Review.

PMID:
17229974
10.

[Alzheimer disease: cellular and molecular aspects].

Octave JN.

Bull Mem Acad R Med Belg. 2005;160(10-12):445-9; discussion 450-1. French.

PMID:
16768248
11.

Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.

Berson A, Knobloch M, Hanan M, Diamant S, Sharoni M, Schuppli D, Geyer BC, Ravid R, Mor TS, Nitsch RM, Soreq H.

Brain. 2008 Jan;131(Pt 1):109-19. Epub 2007 Dec 3.

PMID:
18056160
12.

Neuronal expression of vimentin in the Alzheimer's disease brain may be part of a generalized dendritic damage-response mechanism.

Levin EC, Acharya NK, Sedeyn JC, Venkataraman V, D'Andrea MR, Wang HY, Nagele RG.

Brain Res. 2009 Nov 17;1298:194-207. doi: 10.1016/j.brainres.2009.08.072. Epub 2009 Sep 1.

PMID:
19728994
13.

Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal pathology.

Cataldo AM, Peterhoff CM, Schmidt SD, Terio NB, Duff K, Beard M, Mathews PM, Nixon RA.

J Neuropathol Exp Neurol. 2004 Aug;63(8):821-30.

PMID:
15330337
14.
15.

Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.

Pérez M, Morán MA, Ferrer I, Avila J, Gómez-Ramos P.

Acta Neuropathol. 2008 Oct;116(4):409-18. doi: 10.1007/s00401-008-0420-0. Epub 2008 Aug 5.

PMID:
18679696
16.

Hippocampal estrogen receptor-alpha splice variant TADDI in the human brain in aging and Alzheimer's disease.

Ishunina TA, Swaab DF.

Neuroendocrinology. 2009;89(2):187-99. doi: 10.1159/000158573. Epub 2008 Sep 25.

PMID:
18815440
17.

RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.

Donahue JE, Flaherty SL, Johanson CE, Duncan JA 3rd, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, Stopa EG.

Acta Neuropathol. 2006 Oct;112(4):405-15. Epub 2006 Jul 25.

PMID:
16865397
18.

Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity.

Wilhelmus MM, Boelens WC, Otte-Höller I, Kamps B, Kusters B, Maat-Schieman ML, de Waal RM, Verbeek MM.

Acta Neuropathol. 2006 Feb;111(2):139-49. Epub 2006 Feb 17.

PMID:
16485107
19.

Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease.

Feng Z, Qin C, Chang Y, Zhang JT.

Free Radic Biol Med. 2006 Jan 1;40(1):101-9. Epub 2005 Sep 7.

PMID:
16337883
20.

Supplemental Content

Support Center